Finance

Lists
Why is 51S up 8.33%?
Dive Deeper
51S:FRA
Cynata Therapeutics Ltd
€0.0065
+8.33%
(+0.00050) 1D
Oct 13, 8:04:31 AM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 51S...
Open
€0.01
High
€0.01
Low
€0.01
Mkt. cap
5.22M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.24
52-wk low
€0.00
No. of employees
0
Open
€0.01
High
€0.01
Low
€0.01
Mkt. cap
5.22M
Avg. vol.
0.00
Volume
0.00
52-wk high
€0.24
52-wk low
€0.00
No. of employees
0
News stories
From web sources and news partners
About Cynata Therapeutics Ltd
CEORoss Alexander Macdonald
Employees0
Founded2003
Headquarters-
SectorBiotechnology
Websitecynata.com
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
855.81K
855.81K
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
2.77M
2.77M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.69M
1.69M
-763.69K
-763.69K
Operating expense
2.22M
2.22M
2.63M
2.63M
Total operating expenses
2.22M
2.22M
2.63M
2.63M
Operating income
-1.36M
-1.36M
-2.63M
-2.63M
Other non operating income
-
-
-
-
EBT including unusual items
-1.33M
-1.33M
-3.29M
-3.29M
EBT excluding unusual items
-1.33M
-1.33M
-2.62M
-2.62M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
425.31K
425.31K
527.43K
527.43K
Net income
-1.33M
-1.33M
-3.29M
-3.29M
Net profit margin
-155.55%
-155.55%
-
-
Earnings per share
-
-
-
-
Interest and investment income
30.33K
30.33K
9.42K
9.42K
Interest expense
-
-
-
-
Net interest expenses
30.33K
30.33K
9.42K
9.42K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.30M
-1.30M
-2.56M
-2.56M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps